Integrating sampling techniques and inverse virtual screening: toward the discovery of artificial peptide-based receptors for ligands
暂无分享,去创建一个
Marcello Mascini | Germán M Pérez | Luis A Salomón | Luis A Montero-Cabrera | José M García de la Vega | L. Montero-Cabrera | M. Mascini | J. M. G. de la Vega | Germán M. Pérez | L. A. Salomón
[1] Yanli Wang,et al. Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review , 2012, The AAPS Journal.
[2] Carolina H Andrade,et al. Assessing the performance of 3D pharmacophore models in virtual screening: how good are they? , 2013, Current topics in medicinal chemistry.
[3] Fu Wei,et al. Evaluation of various inverse docking schemes in multiple targets identification. , 2010, Journal of molecular graphics & modelling.
[4] Mark McGann,et al. FRED Pose Prediction and Virtual Screening Accuracy , 2011, J. Chem. Inf. Model..
[5] G. Bifulco,et al. Inverse Virtual Screening allows the discovery of the biological activity of natural compounds. , 2012, Bioorganic & medicinal chemistry.
[6] Jung-Hsin Lin,et al. idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach , 2012, Nucleic Acids Res..
[7] S. Gharaghani,et al. A Structure‐based QSAR and Docking Study on Imidazo[1,5‐a][1,2,4]‐triazolo[1,5‐d][1,4,]benzodiazepines as Selective GABAAα5 Inverse Agonists , 2011, Chemical biology & drug design.
[8] V. Vyas,et al. Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors. , 2013, Journal of molecular graphics & modelling.
[9] Z. Altintas,et al. Computational Design of Peptide Ligands for Ochratoxin A , 2013, Toxins.
[10] Chang-Guo Zhan,et al. Novel human mPGES-1 inhibitors identified through structure-based virtual screening. , 2011, Bioorganic & medicinal chemistry.
[11] Yonghua Wang,et al. Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics , 2011, Journal of Molecular Modeling.
[12] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[13] Peter A. Lieberzeit,et al. Biomimetic Strategies for Sensing Biological Species , 2013, Biosensors.
[14] Chang-Guo Zhan,et al. New inhibitor of 3-phosphoinositide dependent protein kinase-1 identified from virtual screening. , 2012, Bioorganic & medicinal chemistry letters.
[15] M. Carlo,et al. Peptides Trapping Dioxins: A Docking-Based Inverse Screening Approach , 2013 .
[16] Xinping Luo,et al. Docking-based virtual screening of potential human P2Y12 receptor antagonists. , 2011, Acta biochimica et biophysica Sinica.
[17] B. Dong,et al. Docking and molecular dynamics study on the inhibitory activity of N, N-disubstituted-trifluoro-3-amino-2-propanols-based inhibitors of cholesteryl ester transfer protein , 2011, Journal of molecular modeling.
[18] Marcello Mascini,et al. Peptides trapping cocaine: docking simulation and experimental screening by solid phase extraction followed by liquid chromatography mass spectrometry in plasma samples. , 2013, Analytica chimica acta.
[19] Jie Liang,et al. Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds. , 2009, Bioorganic & medicinal chemistry.
[20] Elizabeth Yuriev,et al. Latest developments in molecular docking: 2010–2011 in review , 2013, Journal of molecular recognition : JMR.
[21] B. Padhy,et al. Drug repositioning: re-investigating existing drugs for new therapeutic indications. , 2011, Journal of postgraduate medicine.
[22] Sheng-Yong Yang,et al. Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.
[23] J. Bajorath,et al. State-of-the-art in ligand-based virtual screening. , 2011, Drug discovery today.
[24] Ruben Abagyan,et al. Optimization of High Throughput Virtual Screening by Combining Shape‐Matching and Docking Methods. , 2008 .
[25] Ruth Nussinov,et al. Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.
[26] Y.Z. Chen,et al. Ligand–protein inverse docking and its potential use in the computer search of protein targets of a small molecule , 2001, Proteins.
[27] Gisbert Schneider,et al. Virtual screening and fast automated docking methods. , 2002, Drug discovery today.
[28] David S. Wishart,et al. Development of a Novel Virtual Screening Cascade Protocol to Identify Potential Trypanothione Reductase Inhibitors , 2009, Journal of medicinal chemistry.
[29] Alessandro Pedretti,et al. VEGA – An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming , 2004, J. Comput. Aided Mol. Des..
[30] Xiaoqin Zou,et al. An inverse docking approach for identifying new potential anti-cancer targets. , 2011, Journal of molecular graphics & modelling.
[31] Alexander A. Kantardjiev. Quantum.Ligand.Dock: protein–ligand docking with quantum entanglement refinement on a GPU system , 2012, Nucleic Acids Res..
[32] Fumio Hirata,et al. Systematic docking study of the carbohydrate binding module protein of Cel7A with the cellulose Ialpha crystal model. , 2010, The journal of physical chemistry. B.
[33] Jiwon Choi,et al. Enrichment of virtual hits by progressive shape-matching and docking. , 2012, Journal of molecular graphics & modelling.
[34] Xiaomin Luo,et al. TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..
[35] Douglas R. Houston,et al. Consensus Docking: Improving the Reliability of Docking in a Virtual Screening Context , 2013, J. Chem. Inf. Model..
[36] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[37] Claudio N. Cavasotto,et al. Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models. , 2011, Journal of molecular graphics & modelling.
[38] Thomas Lengauer,et al. Fully Automated Flexible Docking of Ligands into Flexible Synthetic Receptors Using Forward and Inverse Docking Strategies , 2006, J. Chem. Inf. Model..
[39] I. Kuntz. Structure-Based Strategies for Drug Design and Discovery , 1992, Science.
[40] A. Nicholls,et al. Ligand Entropy in Gas-Phase, Upon Solvation and Protein Complexation. Fast Estimation with Quasi-Newton Hessian. , 2010, Journal of chemical theory and computation.
[41] A. Winsor. Sampling techniques. , 2000, Nursing times.
[42] Christopher I. Bayly,et al. Evaluating Virtual Screening Methods: Good and Bad Metrics for the "Early Recognition" Problem , 2007, J. Chem. Inf. Model..
[43] Federico Berti,et al. Short peptides as biosensor transducers , 2012, Analytical and Bioanalytical Chemistry.
[44] I. Chianella,et al. Computational design and synthesis of molecularly imprinted polymers with high binding capacity for pharmaceutical applications-model case: Adsorbent for abacavir , 2006 .
[45] P. Lan,et al. 3D-QSAR and Molecular Docking Studies on Fused Pyrazoles as p38α Mitogen-Activated Protein Kinase Inhibitors , 2010, International journal of molecular sciences.
[46] Anders Wallqvist,et al. Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach , 2012, J. Chem. Inf. Model..
[47] M. Carlo,et al. Multiple Minima Hypersurfaces Procedures for Biomimetic Ligands Screening , 2011 .
[48] Bohdan Waszkowycz,et al. Towards improving compound selection in structure-based virtual screening. , 2008, Drug discovery today.
[49] Luis Alberto Montero-Cabrera,et al. Peptides Binding Cocaine: A Strategy to Design Biomimetic Receptors , 2012 .
[50] Hans-Joachim Böhm,et al. A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.
[51] Edward O. Cannon. New Benchmark for Chemical Nomenclature Software , 2012, J. Chem. Inf. Model..
[52] Sergey A. Piletsky,et al. Rational design of a polymer specific for microcystin-LR using a computational approach. , 2002, Analytical chemistry.
[53] C. Chen,et al. (2S,4S)-1-[2-(1,1-dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino)acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV. , 2010, Bioorganic & medicinal chemistry letters.
[54] Dibyabhaba Pradhan,et al. Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus , 2011, Interdisciplinary Sciences: Computational Life Sciences.
[55] Benjamin A. Ellingson,et al. Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..
[56] Ziniu Yu,et al. Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening , 2011, Journal of molecular modeling.
[57] Ajay N. Jain,et al. Ligand-based structural hypotheses for virtual screening. , 2004, Journal of medicinal chemistry.
[58] Eiichi Akaho,et al. VSDK: Virtual screening of small molecules using AutoDock Vina on Windows platform , 2011, Bioinformation.